The short version of reconstitution fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-22 and is reviewed periodically as new material appears.
Handling begins when a peptide container is opened. Hygroscopic solids can absorb atmospheric water rapidly, so bench work should be brief and containers resealed with fresh desiccant. Weighing or transferring should occur in a low-humidity environment where possible. Static electricity may cause fine powders to cling to surfaces, leading to inaccurate mass measurements. Tools such as antistatic devices or grounded workstations reduce that problem. Good laboratory practice also includes labeling date, lot, and storage condition after each opening.
Reconstitution introduces new variables. The solvent should match the peptide's solubility profile, and water or buffer quality matters because trace metals and microbes can alter results. Adding solvent gently down the vial wall minimizes foaming, which can denature some sequences. Mixing by gentle inversion or swirling is usually preferred over vigorous vortexing. If a peptide does not dissolve readily, adjusting pH or using a small amount of organic co-solvent may help, but such steps can also affect stability and should be documented.
Peptides are short chains of amino acids linked by amide bonds, and their storage stability depends on sequence, length, and three-dimensional structure. Chemical degradation can occur through hydrolysis, oxidation, deamidation, and aggregation, while physical changes such as precipitation or surface adsorption reduce recovery. Storage conditions are chosen to slow these processes without altering the peptide itself. Because peptides vary widely, no single condition suits every sequence, so laboratories often establish stability empirically for each batch.
Temperature is a primary factor because most degradation reactions proceed more slowly at lower temperatures. Lyophilized peptides are commonly held at -20 °C or below, although some sequences remain stable at 2–8 °C for limited periods. Moisture uptake during handling can accelerate hydrolysis, so sealed containers and desiccants are used. Solutions are generally less stable than powders and may require freezing at -80 °C or refrigeration, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation even when the storage temperature is otherwise suitable.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Color and texture vary with sequence and counterion. |
| Reconstitution solvent | Water or aqueous buffer | Organic co-solvent may be needed for hydrophobic sequences. |
| Working aliquot size | Single-use portion | Limits repeated temperature cycling and contamination. |
| Identity method | Mass spectrometry | Confirms molecular mass; paired with chromatographic data. |
| Purity method | RP-HPLC | Separates impurities and variant peptides by hydrophobicity. |
Reconstitution is the process of dissolving a dried peptide in a suitable solvent. The choice of solvent depends on solubility, charge, and sequence; sterile water is common, while buffers or small amounts of organic solvent may be needed for hydrophobic peptides. Adding solvent gently down the vial wall and mixing by inversion or gentle swirling reduces foaming and shear. Vortexing or vigorous pipetting can denature some peptides or promote aggregation. The resulting solution should be visually inspected for particles, turbidity, and complete dissolution before use.
After reconstitution, solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. Aliquots should be labeled with peptide identity, concentration, solvent, and date, then stored at the temperature specified by the supplier or protocol. Many peptides tolerate -20 °C for short periods, while -80 °C is preferred for longer storage. Frost-free freezers are generally avoided because temperature fluctuations can stress samples. Aseptic technique and sterile filters reduce microbial contamination, though filtration can also remove aggregated material or bind some peptides.
Peptides are short chains of amino acids whose physical and chemical stability depends on sequence, length, and conformation. The amide backbone can hydrolyze under acidic or basic conditions, while side chains such as methionine, cysteine, and tryptophan are prone to oxidation. Aggregation may occur when hydrophobic regions associate, especially near surfaces or at high concentration. Because these pathways differ among peptides, no single storage condition applies to all sequences. Stability studies therefore examine each peptide under defined temperature, pH, and humidity ranges.
Temperature is a primary variable because most degradation reactions slow as thermal energy decreases. Lyophilized powders are commonly held at -20 °C for routine work and at -80 °C for longer archival periods, though exact recommendations depend on the peptide. Solutions are less stable than dry powders in many cases, and repeated freeze-thaw cycles can promote aggregation or precipitation. Inert atmospheres, such as argon or nitrogen, can limit oxidation for oxygen-sensitive sequences. Desiccants reduce water activity, which lowers hydrolysis rates during storage.
Light exposure can damage aromatic residues and certain labels, so amber vials or opaque containers are often used. pH control matters in solution, as extreme acidity or alkalinity accelerates backbone cleavage; buffers may also introduce ions that affect solubility. Microbial growth is a concern for aqueous preparations that lack preservatives, though many research peptides are handled in sterile or low-bioburden conditions. Container materials can adsorb peptides, particularly hydrophobic or positively charged sequences, reducing recovery. These factors interact, meaning storage decisions balance chemical stability, physical state, and intended use.
== Further reading == Press Conference by professor Samuel S. Epstein M.D. 1999-05-31 World Trade Organization (2000). Dispute Settlement Reports 1998. Cambridge University Press. p. 79. ISBN 0-521-78895-1. Galbraith, H. (December 2002). "Hormones in international meat production: biological, sociological and consumer issues". Nutrition Research Reviews. 15 (2). CABI Publishing: 293–314. doi:10.1079/NRR200246. PMID 19087409. M. Ellin Doyle. "Human Safety of Hormone Implants Used to Promote Growth in Cattle". National Cattlemen's Foundation. Archived from the original (Microsoft Word) on 7 May 2006. J. J. Kastner & R. K. Pawsey (29 November 2001). "Harmonising sanitary measures and resolving trade disputes through the WTO–SPS framework. Part I: a case study of the US–EU hormone-treated beef dispute" (PDF). Food Control. 13. Elsevier Science Ltd.: 49–55. doi:10.1016/S0956-7135(01)00023-8. Archived from the original (PDF) on 21 May 2004. Tim Josling; Donna Roberts & Ayesha Hassan (12 April 2000). "The Beef-Hormone Dispute and its Implications for Trade Policy" (PDF). Stanford University. Archived from the original (PDF) on 11 June 2007. Grace Skogstad (September 2001). "The WTO and Food Safety Regulatory Policy Innovation in the European Union". Journal of Common Market Studies. 39 (3): 485–505. doi:10.1111/1468-5965.00300. Christina L. Davis (2003). "Battles over Beef: The Beef Hormone Dispute". Food Fights Over Free Trade: How International Institutions Promote Agricultural Trade Liberalization. Princeton University Press. pp. 321–337. ISBN 0-691-11505-2.
Created by writer Chris Claremont, Elizabeth "Betsy" Braddock first appeared in Captain Britain #8 (December 1976), with Captain Britain #10 (December 1976) as her first cover appearance, published by the Marvel Comics' British imprint Marvel UK. In New Mutants Annual #2 (1986), Claremont integrated Betsy Braddock into the X-Men franchise. After being rescued by the New Mutants and taking up residence at their mutant-training academy, Braddock is formally invited to join the X-Men and officially adopts the codename Psylocke, becoming an enduring fixture of the team over the next three decades. In Uncanny X-Men #213 (January 1987), Psylocke battles Sabretooth, demonstrating her fighting skills by holding him at bay. In Uncanny X-Men #256 (December 1989), an amnesiac Betsy is kidnapped by the Hand, who brainwash her and physically alter her to take on an East Asian appearance. Under the name Lady Mandarin, she briefly becomes the Hand's supreme assassin. While her memories return, she retains her new appearance and skills, including the ability to manifest the focused totality of her telepathic power in the form of a “psychic knife.” The art for Psylocke's redesigned costume is by Jim Lee. In a later interview, he describes the creative process:
The toxicity may also result from non-combustible sources such as the one released from anaerobic fermentation of food grains and anaerobic digestion of biodegradable waste. The World Health Organization (WHO) developed a global recommendation limiting exposures to less than 20 parts per billion for chronic exposure and value less 100 ppb for one hour for acute exposure, using nitrogen dioxide as a marker for other pollutants from fuel combustion. There is a significant association between indoor NO2 levels and increased respiratory symptoms such as wheeze, chest tightness and severity of infections among children with asthma. Historically, some cities in the United States including Chicago and Los Angeles have higher levels of nitrogen dioxide than the EPA maximum exposure limits of 100 ppb for a one-hour exposure and less than 53 ppb for chronic exposure.
Sources: en.wikipedia.org
Glycerol is used in medical, pharmaceutical and personal care preparations, often as a means of improving smoothness, providing lubrication, and as a humectant. Ichthyosis and xerosis have been relieved by the topical use of glycerin. It is found in allergen immunotherapies, cough syrups, elixirs, expectorants, toothpastes, mouthwashes, skin care products, shaving cream, hair care products, soaps, and water-based personal lubricants. It is used to keep tablets and other solid dosage forms from falling apart. For human consumption, glycerol is classified by the FDA among the sugar alcohols as a caloric macronutrient. Glycerol is also used in blood banking to preserve red blood cells prior to freezing. Taken rectally, glycerol functions as a laxative by irritating the anal mucosa and inducing a hyperosmotic effect, expanding the colon by drawing water into it to induce peristalsis resulting in evacuation. It may be administered undiluted as a suppository, or as a small-volume (2–10 ml) enema. Alternatively, it may be administered in a dilute solution, such as 5%, as a high-volume enema. Taken orally (often mixed with fruit juice to reduce its sweet taste), glycerol can cause a rapid, temporary decrease in the internal pressure of the eye. This can be useful for the initial emergency treatment of severely elevated eye pressure. In 2017, researchers showed that the probiotic Limosilactobacillus reuteri bacteria can be supplemented with glycerol to enhance its production of antimicrobial substances in the human gut.
Both enantiomers of alazocine have very low affinity for the sigma σ2 receptor (Ki = 13,694 nM and 4,581 nM for the (+)- and (−)-enantiomers, respectively, in rat brain membranes or rat PC12 cells). As such, due to its high affinity for the σ1 receptor, (+)-alazocine can be used to distinguish between the two sigma receptor subtypes in scientific research, for instance in radioligand binding assays. Taken together, (−)-alazocine is a selective partial agonist of the κ-opioid receptor, antagonist of the μ-opioid receptor, and to a far lesser extent agonist of the δ-opioid receptor with very low affinity for the sigma receptors, while (+)-alazocine is a selective agonist of the sigma σ1 receptor and to a lesser (~10-fold) extent antagonist of the NMDA receptor with low affinity for the opioid and sigma σ2 receptors.
== External links == Somatotropin+receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Illustration at nih.gov Overview Growth Hormone Receptor Archived 2015-10-16 at the Wayback Machine: Molecule of the Month by Shuchismita Dutta and David Goodsell (April 2004) PDBe-KB provides an overview of all the structure information available in the PDB for Human Growth hormone receptor
Canada (1974) Australia (1981) Israel (1983) UK (1987) Netherlands (2010) In 2012, JDF changed its name to Juvenile Diabetes Research Foundation, which was later shortened to JDRF. In 2019, JDRF International appointed its first-ever CEO and president with type 1 diabetes, Dr. Aaron Kowalski. In 2024, the international chapters of the organization began to change their name from JDRF to Breakthrough T1D, reflecting its focus on helping people of all ages and in line with growing awareness that T1D affects people of all ages. The Australian affiliate was the last to change their name on March 31, 2025.
Sources: en.wikipedia.org
Aliquoting divides a stock into portions that can be thawed once and used without returning the whole batch to storage. This limits temperature cycling and reduces the chance of contamination or concentration changes. It also makes it easier to track how many portions remain.
Mass spectrometry is commonly used because it measures molecular mass and can reveal sequence truncations or modifications. Chromatographic retention time adds complementary information about purity and hydrophobicity. Neither method alone proves full structural integrity, so results are interpreted together.
Aqueous peptide solutions generally have shorter shelf lives than dry powders because water enables hydrolysis, oxidation, and microbial growth. Storage time depends on sequence, buffer, concentration, and temperature. Stability testing or supplier guidance should determine acceptable holding periods for a specific material.
Removing water reduces hydrolytic and some oxidative degradation. Powder forms are generally more stable for long-term storage than solutions. Stability still depends on peptide sequence, residual moisture, and container conditions.